Nasdaq halts trading in Artiva Biotherapeutics pending news
ARTV•Nasdaq halted trading in Artiva Biotherapeutics pending news at 7:25 a.m.
Related News

Simply Good Foods forecasts fiscal 2027 net sales decline of 13%-17%
SMPL•

RTX CFO Neil Mitchill to speak at Baird Global Industrial Conference
RTX•

Mazda selects CCC Intelligent Solutions to deliver parts promotional pricing
CCC•

OPKO Biologics doses first participant in Phase 1/2a trial of acromegaly drug
OPK•

PhotonDelta says manufacturing scale drives competitiveness in integrated photonics
SMH•